FDA Decisions Expected: May 2025 - Prime Therapeutics
FDA Decisions Expected: May 2025
National Cancer Institute. Pancreatic Cancer Treatment (PDQ)- Patient Version. Retrieved on April 9, 2025 from https://www.cancer.gov/types/pancreatic/patient/pancreatic-treatment-pdq.
Prime Therapeutics’ FDA Decisions Expected outlines upcoming FDA approvals for new drugs or indications that could impact health care costs and patient care. It highlights key therapies, their potential clinical value, and their anticipated financial implications for health plans and stakeholders.
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.